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Background
A role for drug-specific T cells has been demonstrated in
many instances of drug hypersensitivity. In the case of
-lactam antibiotics, such as flucloxacillin, we have shown
that drug-protein conjugates are present in the plasma of
all patients treated with this antibiotic, however only a
small subset of patients develop hypersensitivity. Similarly,
when a strong HLA association to drug hypersensitivity
has been demonstrated such as for abacavir, not all
patients with the risk allele will develop a hypersensitivity
reaction. The mechanism underlying this variation in
susceptibility is not fully understood. In carbamazepine-
induced Stevens Johnson syndrome it is known that only
patients with both the HLA risk allele and T cells with a
specific TCR V will develop a reaction. This shows that an
individual’s T cell repertoire may confer some susceptibility
to drug hypersensitivity.
Method
In initial experiments, SMX-NO-specific CD4+ clones
were generated from hypersensitive patients and analysed
for TCR V expression. Nitroso sulfamethoxazole (SMX-
NO)-specific T cells were generated from 6 individuals
by priming naïve T-cells using drug-treated autologous
dendritic cells. The responding cells were isolated using
positive CD45RO magnetic bead selection. Naïve and
SMX-NO specific T cells were analysed by serology for
24 TCR Vs and by RT-PCR spectra-typing of the CDR3
region.
Results
There was a marked expansion of TCR V4 and V9 in
5 donors, of TCR V11, V13.6 and V14 in 4 donors and
of TCR V5.2 and V18 in 3 donors. We were able to
show clonal expansion of these individual TCR Vs using
CDR3 spectratyping analysis.
Conclusion
This data suggests that there may be a skewing of the
T cell repertoire in SMX-NO specific responses.
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